Cell and Gene Commercialization

  1. Maintain Control Over Your Regulatory Path And Mitigate Risks 7/18/2024

    Our expertise spans the entire drug development process, navigating challenges posed by globalization, stakeholder engagement, scientific innovation, and payer expectations.

  2. Insights into Global Non-Small Cell Lung Cancer Research 7/3/2024

    This FAQ section delves into non-small cell lung cancer (NSCLC) incidence, current trials, innovative drugs, and their effects on patient outcomes.

  3. Radiopharmaceutical Therapy: Global Clinical Trial Insights 2024 7/3/2024

    By downloading this report, readers will uncover the transformative potential of radiopharmaceuticals in cancer therapy and stay ahead in the evolving cancer treatment landscape.

  4. Non-Small Cell Lung Cancer — Global Clinical Trial Landscape (2024) 7/3/2024

    Explore cutting-edge Non-Small Cell Lung Cancer (NSCLC) research with Novotech CRO's in-depth disease analysis, providing insights into innovative therapies, clinical trials, and future directions shaping NSCLC care globally.

  5. Liver Cancer — Global Clinical Trial Landscape (2024) 7/3/2024

    Explore the latest advancements and clinical trial landscape in liver cancer research with Novotech CRO's comprehensive disease report.

  6. The Current State Of Cell Therapy Manufacturing 7/3/2024

    Expert panelists on Cell & Gene Live, Inside Next-Gen Platforms for Cell Therapy Manufacturing, share their points of view on cell therapy manufacturing as it stands today.

  7. Inside Next-Gen Platforms For Cell Therapy Manufacturing 6/28/2024

    With additional cell therapy approvals on the horizon, diverse products and platforms are needed to help ensure safety and efficacy in manufacturing, increase speed to market, and decrease overall CoGS.

  8. Pre-Launch Checklist - A Roadmap To Success 6/21/2024

    The path from groundbreaking therapy to readily available treatment requires a strategic approach. Delve into ten critical questions that can help you chart a successful course for your CGT therapy.

  9. Cell And Gene Therapy (CGT): Pre-Launch Checklist 6/17/2024

    Discover the ten questions to ask yourself and your commercialization partner to chart a comprehensive strategy that aims to support the successful advancement of your therapy.

  10. IP Considerations For Gene Editing In The Cell Therapy Space 6/13/2024

    It is crucial to monitor the IP landscape and file patent applications for advancements. By staying informed and proactive, companies can secure their position in the rapidly evolving CGT field.